JP2007204426A - Hair growth promoter - Google Patents

Hair growth promoter Download PDF

Info

Publication number
JP2007204426A
JP2007204426A JP2006025226A JP2006025226A JP2007204426A JP 2007204426 A JP2007204426 A JP 2007204426A JP 2006025226 A JP2006025226 A JP 2006025226A JP 2006025226 A JP2006025226 A JP 2006025226A JP 2007204426 A JP2007204426 A JP 2007204426A
Authority
JP
Japan
Prior art keywords
hair
hair growth
coenzyme
effect
growth promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006025226A
Other languages
Japanese (ja)
Inventor
Koji Takehara
孝二 竹原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Cosmetics Inc
Original Assignee
Kanebo Cosmetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Cosmetics Inc filed Critical Kanebo Cosmetics Inc
Priority to JP2006025226A priority Critical patent/JP2007204426A/en
Publication of JP2007204426A publication Critical patent/JP2007204426A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a hair growth promoter having excellent hair-growing, hair-nourishing, hair loss-preventing and dandruff-preventing actions on alopecia. <P>SOLUTION: The hair growth promoter contains a peripheral blood flow promoting agent such as γ-aminobutyric acid derivative, nicotinic acids, vitamin E compounds, trans-3,4'-dimethyl-3-hydroxyflavanone and 6-benzylaminopurine, and a coenzyme such as coenzyme Q10 and α-lipoic acid. The invention further provides a hair growth promoter containing an extract of Reishi fungus or Ligusticum acutilobum in addition to the above components. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、育毛料に関し、更に詳しくは、発毛、養毛、脱毛予防、ふけ防止等の効果に優れた育毛料に関する。本発明の育毛料は、具体的には、医薬品、医薬部外品又は化粧品の分野において利用される。   The present invention relates to a hair growth material, and more particularly, to a hair growth material excellent in effects such as hair growth, hair growth, hair loss prevention, and anti-dandruff. The hair restorer of the present invention is specifically used in the field of pharmaceuticals, quasi drugs or cosmetics.

一般的に、脱毛症は血行の不全、毛母細胞活性の低下や性ホルモンのアンバランス等の様々な要因が複雑に絡み合って生じていると考えられ、特に現代社会は高齢化社会、ストレス社会と言われるように、様々な原因によって脱毛の危機にさらされる機会が多くなっている。しかし、脱毛の発生機作やメカニズムが未だ十分に解明されていないのが現状である。従来の育毛料には育毛効果が期待される薬効成分として、例えば、トウガラシチンキ、センブリエキス、朝鮮ニンジンエキス、ニコチン酸誘導体等の頭皮の血行促進物質、セファランチン等の皮膚機能亢進物質、アセチルコリン誘導体等の血管拡張剤、エストラジオール等の女性ホルモン剤、パントテン酸誘導体等のメラニン合成触媒剤、サリチル酸、レゾルシン等の角質溶解剤、グリチルレチン酸、アズレン等の抗炎症剤が配合され、脱毛の予防や治療に用いられている(例えば、非特許文献1参照。)。しかしながら、これらの成分は、頭皮の養毛環境を整えたり、すでに生えている毛髪の成長速度を改善したりする効果があるものの、発毛作用が弱く、更に場合によっては皮膚刺激を引き起こしたりするため、配合量に制限があり、十分な効果を発揮するまでには至っていない。育毛料においては新生毛の発生を促すことも重要であり、発毛促進物質としてミノキシジルが配合された発毛料(例えば、特許文献1、2参照。)が報告されているが、本物質は血圧降下作用を応用したものであり、副作用等を伴い安全性という観点で懸念される。またコエンザイムQ10を含有した育毛料(例えば、特許文献3、4参照。)が報告されているが、発毛・養毛効果においてはその効果が充分であるとは言えず、その為、発毛効果と養毛効果を兼ね備えた、より効果的な育毛料が強く要望されている。   In general, alopecia is thought to be caused by complex intertwining of various factors such as poor blood circulation, decreased hair matrix activity, and sex hormone imbalance. Especially in modern society, aging society and stress society As said, there are many opportunities to be at risk of hair loss due to various causes. However, the mechanism and mechanism of hair loss have not been fully elucidated yet. As a medicinal ingredient expected to have a hair-growth effect in conventional hair-growth materials, for example, red pepper tincture, assembly extract, ginseng extract, nicotinic acid derivative and other scalp blood circulation promoting substances, cephalanthin and other skin function enhancing substances, acetylcholine derivatives and the like Vascular dilators, female hormone agents such as estradiol, melanin synthesis catalyst agents such as pantothenic acid derivatives, keratolytic agents such as salicylic acid and resorcin, and anti-inflammatory agents such as glycyrrhetinic acid and azulene are combined to prevent and treat hair loss. It is used (for example, refer nonpatent literature 1). However, these ingredients have the effect of adjusting the hair growth environment of the scalp and improving the growth rate of hair that has already grown, but have a weak hair growth action and may cause skin irritation in some cases. Therefore, there is a limit to the amount of blending, and it has not yet reached a sufficient effect. In hair restorations, it is also important to promote the generation of new hair, and hair growth preparations containing minoxidil as a hair growth promoting substance (for example, see Patent Documents 1 and 2) have been reported. This is an application of a lowering action, and has side effects and is concerned from the viewpoint of safety. Further, although hair growth agents containing coenzyme Q10 (see, for example, Patent Documents 3 and 4) have been reported, it cannot be said that the hair growth / hair growth effect is sufficient, and therefore hair growth. There is a strong demand for a more effective hair restorer that has both an effect and a hair nourishing effect.

田島正裕著「育毛剤の現状と課題」フレグランスジャーナル、1997年5月、p.43−51Tajima Masahiro “Current Status and Challenges of Hair Growth Agents” Fragrance Journal, May 1997, p. 43-51 特開平5−4908号公報Japanese Patent Laid-Open No. 5-4908 特開平7−53338号公報JP-A-7-53338 特許第2969179号公報Japanese Patent No. 2969179 特開2002−332217号公報JP 2002-332217 A

本発明の目的とするところは、脱毛症に対して優れた発毛、養毛、脱毛予防、ふけ防止作用を有する育毛料を提供するにある。   An object of the present invention is to provide a hair-growth agent having an effect of hair growth, hair growth, hair loss prevention and anti-dandruff which is excellent against alopecia.

即ち、本発明の請求項1の発明は、末梢血流促進剤と補酵素を含有することを特徴とする育毛料であり、請求項2の発明は、末梢血流促進剤が、γ−アミノ酪酸誘導体、ニコチン酸類、ビタミンE類、トランス−3,4´−ジメチル−3−ヒドロキシフラバノン、6
−ベンジルアミノプリンからなる群より選ばれる少なくとも一種以上である請求項1記載の育毛料であり、請求項3の発明は、補酵素がコエンザイムQ10またはα−リポ酸から選ばれる1種類以上を配合する育毛料である。
That is, the invention of claim 1 of the present invention is a hair restorer containing a peripheral blood flow promoter and a coenzyme, and the invention of claim 2 is characterized in that the peripheral blood flow promoter is γ-amino. Butyric acid derivatives, nicotinic acids, vitamin E, trans-3,4'-dimethyl-3-hydroxyflavanone, 6
The hair growth material according to claim 1, which is at least one selected from the group consisting of -benzylaminopurine, and the invention according to claim 3 contains one or more coenzymes selected from coenzyme Q10 or α-lipoic acid. It is hair restorer.

本発明者は、上記目的を達成するために、鋭意研究を重ねた結果、γ−アミノ酪酸誘導体、ニコチン酸類等の末梢血流促進剤と、コエンザイムQ10、α−リポ酸等の補酵素とを組み合わせて、さらに好ましくは、レイシ、トウヒから抽出されたエキスを配合することにより、発毛促進効果、毛成長促進に優れた効果を示し、更に脱毛抑制効果及びふけ防止予防効果にも著しい効果を呈することを見出して本発明を完成するに至った。   As a result of intensive studies to achieve the above object, the present inventor has obtained a peripheral blood flow promoter such as a γ-aminobutyric acid derivative and nicotinic acid, and a coenzyme such as coenzyme Q10 and α-lipoic acid. In combination, more preferably, by blending an extract extracted from litchi and spruce, it exhibits an effect of promoting hair growth and promoting hair growth, and also has a significant effect on hair loss inhibiting effect and anti-dandruff preventing effect. As a result, the present invention has been completed.

以下、本発明の実施形態について詳述する。   Hereinafter, embodiments of the present invention will be described in detail.

本発明に係る育毛料には、第一の必須成分として末梢血流促進剤が配合される。末梢血流促進剤としては、ジイソプロピルアミンジクロロアセテート、γ−アミノ酪酸誘導体、ニコチン酸類、ミノキシジル類、ヒノキチオール、ビタミンE類、塩化カプロニウム、ヨウ化ニンニクエキス、カンフル、ノニル酸バニリルアミド、ペンタデカン酸グリセリル、トランス−3,4´−ジメチル−3−ヒドロキシフラバノン、6−ベンジルアミノプリン、イチョウ抽出物、オトギリ草抽出物、トウガラシチンキ、カンタリスチンキ等が挙げられる。これらの中でも、ジイソプロピルアミンジクロロアセテート、γ−アミノ酪酸誘導体、ニコチン酸類、ビタミンE類、トランス−3,4´−ジメチル−3−ヒドロキシフラバノン、6−ベンジルアミノプリンが好ましい。   The hair restorer according to the present invention contains a peripheral blood flow promoter as the first essential component. Peripheral blood flow promoters include diisopropylamine dichloroacetate, γ-aminobutyric acid derivatives, nicotinic acids, minoxidil, hinokitiol, vitamin E, capronium chloride, garlic iodide extract, camphor, nonyl acid vanillylamide, glyceryl pentadecanoate, trans -3,4'-dimethyl-3-hydroxyflavanone, 6-benzylaminopurine, Ginkgo biloba extract, Hypericum herb extract, Pepper tincture, Cantalis tincture and the like. Among these, diisopropylamine dichloroacetate, γ-aminobutyric acid derivatives, nicotinic acids, vitamin Es, trans-3,4'-dimethyl-3-hydroxyflavanone, and 6-benzylaminopurine are preferable.

γ−アミノ酪酸誘導体としては、γ−アミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸を挙げることができ、脳代謝関連物質として公知の物質であり、現在市販されており、γ−アミノ酪酸(科研製薬社製)、バイサミン(科研製薬社製)が挙げられる。ニコチン酸類としては、ニコチン酸ベンジル,ニコチン酸トコフェロール,ニコチン酸β−ブトキシエチル、ニコチン酸アミド、酒石酸ニコチニックアルコール等を挙げることができ、これらのニコチン酸類は、現在市販されているものを使用することができる。   Examples of γ-aminobutyric acid derivatives include γ-aminobutyric acid and γ-amino-β-hydroxybutyric acid, which are known as brain metabolism-related substances and are currently commercially available. Pharmaceutical Co., Ltd.) and Visamine (Kaken Pharmaceutical Co., Ltd.). Examples of nicotinic acids include benzyl nicotinate, tocopherol nicotinate, β-butoxyethyl nicotinate, nicotinic acid amide, nicotinic alcohol tartrate, etc., and these nicotinic acids are those currently on the market. be able to.

ビタミンE類としては、α−トコフェロール、酢酸DL−α−トコフェロール,ニコチン酸トコフェロール、天然ビタミンE等を挙げることができる。これらのビタミンE類は、現在市販されており、E−ミックスD(岩瀬コスファ社製)、理研Eアセテートα(理研ビタミン社製)、酢酸d−α−トコフェロール(佐々木化学社製)などが挙げられ、また公知の製造方法により製造することができる。トランス−3,4´−ジメチル−3−ヒドロキシフラバノン、6−ベンジルアミノプリンは、現在市販されており、また、公知の製造方法により製造することができる。   Examples of vitamin E include α-tocopherol, DL-α-tocopherol acetate, tocopherol nicotinate, natural vitamin E, and the like. These vitamin Es are currently commercially available, and include E-mix D (manufactured by Iwase Kosfa), RIKEN E Acetate α (manufactured by RIKEN VITAMINS), and d-α-tocopherol acetate (manufactured by Sasaki Chemical Co., Ltd.). In addition, it can be manufactured by a known manufacturing method. Trans-3,4′-dimethyl-3-hydroxyflavanone and 6-benzylaminopurine are currently commercially available and can be produced by known production methods.

本発明においては、これら末梢血流促進剤の中から、一種又は二種以上を適宜選択して用いることができる。これら、末梢血流促進剤の配合量は、育毛料の総量を基準として通常0.001〜10.0質量%(以下、%とする)であり、好ましくは、0.02〜3.0%である。血流促進剤の配合量が、0.001%未満では、充分な効果を発揮することができない場合があり、また10.0%を超えると、皮膚刺激が生ずる等、安全性の点から問題が生じるおそれがあり好ましくない。   In the present invention, one or more of these peripheral blood flow promoters can be appropriately selected and used. The blending amount of these peripheral blood flow promoters is usually 0.001 to 10.0% by mass (hereinafter referred to as%), preferably 0.02 to 3.0%, based on the total amount of hair restorer. It is. If the blending amount of the blood flow promoter is less than 0.001%, sufficient effects may not be exhibited. If it exceeds 10.0%, skin irritation may occur, which is a problem from the viewpoint of safety. May occur, which is not preferable.

本発明に係る育毛料には、第二の必須成分として、補酵素が配合される。補酵素としては、アデノシン三リン酸、コチンアミドアデニンジヌクレオチド、ニコチンアミドアデニンジヌクレオチドリン酸、フラビンアデニンジヌクレオチド、補酵素A、α−リポ酸、チアミンピロリン酸、ピリドキサルリン酸、テトラヒドロ葉酸、UDPグルコース、補酵素
Q10、ビオチン、補酵素B12、S−アデノシルメチオニンなどが好適に用いられる。また、より好ましくは、補酵素Q10またはα−リポ酸から選ばれる補酵素を1種類以上配合することである。
A coenzyme is blended as a second essential component in the hair restorer according to the present invention. As coenzymes, adenosine triphosphate, cotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate, flavin adenine dinucleotide, coenzyme A, α-lipoic acid, thiamine pyrophosphate, pyridoxal phosphate, tetrahydrofolate, UDP glucose Coenzyme Q10, biotin, coenzyme B12, S-adenosylmethionine and the like are preferably used. More preferably, one or more coenzymes selected from coenzyme Q10 or α-lipoic acid are blended.

これらの補酵素の好ましい配合量は、本発明の育毛料中に、0.0001〜1%、より好ましくは0.001〜0.5%である。0.0001%未満では、配合しても本発明の効果が発揮されない場合があり、1%を越えると、強い着色や低温での澱が生じる場合があり好ましくない。   A preferable blending amount of these coenzymes is 0.0001 to 1%, more preferably 0.001 to 0.5% in the hair growth material of the present invention. If it is less than 0.0001%, the effect of the present invention may not be exhibited even if it is blended. If it exceeds 1%, strong coloring and low-temperature starch may occur, which is not preferable.

また、本発明の育毛料には、第三の成分として、レイシ、トウヒから抽出されたエキスを配合することで、より優れた効果を発揮することができる。レイシ、トウヒから抽出されたエキスとしては、水あるいは1,3−ブチレングリコールなどの溶媒に抽出された、水溶解性のエキスが好ましく、例えば、レイシ抽出液BG-J(丸善製薬社製)、トウヒリキッドB(一丸ファルコス社製)などが挙げられる。   Moreover, the hair restorer of this invention can exhibit the more outstanding effect by mix | blending the extract extracted from a lychee and spruce as a 3rd component. As an extract extracted from litchi and spruce, a water-soluble extract extracted in a solvent such as water or 1,3-butylene glycol is preferable. For example, litchi extract BG-J (manufactured by Maruzen Pharmaceutical Co., Ltd.), Sue Hill Liquid B (manufactured by Ichimaru Falcos) and the like.

これらのレイシ、トウヒから抽出されたエキスの好ましい配合量は、本発明の育毛料中に、0.0001〜1%、より好ましくは0.001〜0.5%である。0.0001%未満では、配合しても本発明の効果が発揮されない場合があり、1%を越えると、強い着色や低温での澱が生じる場合があり好ましくない。   The preferable compounding quantity of the extract extracted from these litchi and spruce is 0.0001 to 1% in the hair restorer of this invention, More preferably, it is 0.001 to 0.5%. If it is less than 0.0001%, the effect of the present invention may not be exhibited even if it is blended. If it exceeds 1%, strong coloring and low-temperature starch may occur, which is not preferable.

本発明の育毛料は、種々の形態で用いることができ、例えば、ヘアートニック、ヘアーローション、ヘアークリーム、シャンプー、リンス、ヘアーフォーム、ヘアージェル、エアゾール等の直接頭皮に塗布する剤形に配合し、常法に従い製造することができる。   The hair restorer of the present invention can be used in various forms, for example, blended into a dosage form to be applied directly to the scalp such as hair tonic, hair lotion, hair cream, shampoo, rinse, hair foam, hair gel, aerosol, etc. Can be produced according to a conventional method.

また本発明の育毛料には、前記の各成分に加えて必要に応じて、かつ本発明の効果を損なわない範囲において、化粧品、医薬部外品、医薬品等において一般的に用いられる各種の成分、例えば、油分、保湿剤、増粘剤、色素、香料、殺菌剤、防腐剤、紫外線吸収剤、溶剤、水、角質溶解剤、抗炎症剤、抗アンドロゲン剤、育毛剤、抗酸化剤、清涼剤、生薬抽出物やビタミン類等を適宜配合することができる。   In addition to the above-mentioned components, the hair-care product of the present invention includes various components that are generally used in cosmetics, quasi-drugs, pharmaceuticals, etc. as necessary and within a range that does not impair the effects of the present invention. , For example, oil, moisturizer, thickener, dye, fragrance, bactericidal agent, antiseptic, UV absorber, solvent, water, keratolytic agent, anti-inflammatory agent, anti-androgen agent, hair restorer, antioxidant, refreshing Agents, herbal extracts, vitamins and the like can be appropriately blended.

以下、実施例により本発明を具体的に説明するが、これらの実施例により本発明の技術範囲が限定されるものではない。尚、実施例に記載の毛乳頭細胞増殖促進効果試験、毛成長促進効果試験、脱毛防止効果試験、及びふけ防止効果試験に関する試験法を下記に示す。   EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, the technical scope of this invention is not limited by these Examples. In addition, the test method regarding the hair papillary cell proliferation promotion effect test, the hair growth promotion effect test, the hair loss prevention effect test, and the anti-dandruff effect test described in Examples is shown below.

(1)毛乳頭細胞増殖促進効果試験法
培養毛乳頭細胞を24穴プレートに1穴あたり2×104個の細胞を撒き、24時間37℃のCOインキュベーターでプレインキュベーションし、1mLの試験試料を添加し、24時間プレインキュベーションした。これらに、1穴あたり0.5μCiのH−サイジミンを含む1mLの被験試料を添加して6時間インキュベーションした。その後細胞を2回洗浄した後、10%TCAを添加、4℃で10分間放置、その後TCAを取り除き、水酸化ナトリウムでアルカリ加水分解した後、蟻酸で中和し、シンチレーションカクテルを加えて、放射活性を測定し、DNA合成レベルを調べた。増殖効果の判定は、コントロールと比較し、下記の式にて増殖効果を評価した。
毛乳頭細胞増殖促進効果= (B)/(A)
(A):コントロール(比較例1)の毛乳頭細胞増殖促進効果(dpm/104cells)
(B):実施例、比較例の試料における毛乳頭細胞増殖促進効果(dpm/104cells)
注;dpm=1/30 Bq
(1) Test method for promoting proliferation of dermal papilla cells 2 × 10 4 cells per well of cultured dermal papilla cells in a 24-well plate, preincubated for 24 hours in a CO 2 incubator at 37 ° C., and 1 mL test sample Was added and preincubated for 24 hours. To these, 1 mL of a test sample containing 0.5 μCi of 3 H-thydimine per well was added and incubated for 6 hours. Thereafter, the cells were washed twice, 10% TCA was added, allowed to stand at 4 ° C. for 10 minutes, TCA was then removed, alkali hydrolysis with sodium hydroxide was performed, neutralized with formic acid, scintillation cocktail was added, and radiation was performed. Activity was measured and DNA synthesis levels were examined. The determination of the proliferation effect was compared with the control, and the proliferation effect was evaluated by the following formula.
Hair papilla cell proliferation promoting effect = (B) / (A)
(A): Effect of control (Comparative Example 1) on proliferation of dermal papilla cells (dpm / 10 4 cells)
(B): Hair papillary cell proliferation promoting effect (dpm / 10 4 cells) in the samples of Examples and Comparative Examples
Note: dpm = 1/30 Bq

(2))ヒト頭皮毛成長促進効果試験法
男性型脱毛症患者である被試験者10名の頭部、耳の上5cmの位置にある頭髪を左右2カ所に於いて直径1cmの円形状に剃毛した被験部位に、実施例及び比較例の各試料を左側に毎日朝夕2回、約3mL塗布し、無処置の右側と比較した。効果の判定は、試験開始後28日目に、左右の被験部位の毛髪各々20本ずつを剃毛し、下記の式で求めた値で毛成長促進度を評価した。
毛成長促進度 = (D)/(C)
(C):右側(無処置)の毛20本の長さの平均値
(D):左側(実施例及び比較例の試料を塗布)の毛20本の長さの平均値
(2) Human scalp hair growth promoting effect test method The head of 10 test subjects who are male pattern baldness patients, and the head hair located 5 cm above the ear in a circular shape with a diameter of 1 cm at two left and right positions. About 3 mL of each sample of Examples and Comparative Examples was applied to the left side twice daily in the morning and evening on the shaved test site, and compared with the untreated right side. On the 28th day after the start of the test, the effect was determined by shaving 20 hairs on each of the left and right test sites, and evaluating the degree of hair growth promotion with the value determined by the following formula.
Hair growth promotion level = (D) / (C)
(C): Average value of the length of 20 hairs on the right side (no treatment) (D): Average value of the length of 20 hairs on the left side (the sample of the example and the comparative example applied)

(3)ヒト脱毛防止試験法
男性型脱毛症患者である被試験者10名の頭部に毎日朝夕2回、4カ月間塗布し、試験開始前に専門美容師により洗髪を3日間行った。洗髪時に抜けた毛髪を採取し、その本数を計測し、1日当りの抜け毛本数を算出した。試料塗布後の4ヶ月目に再度専門美容師により洗髪を3日間行い、洗髪時に抜けた毛髪を採取、本数計測を行い、1日当りの抜け毛本数を算出した。試験開始前と4ヶ月後の1日あたりの抜け毛本数を下記の式で求めた値で脱毛防止効果を評価した。
脱毛防止効果(%) = (F)/(E)
(E):塗布前の1日あたりの抜け毛本数
(F):塗布4ヶ月後の1日あたりの抜け毛本数
(3) Human Hair Loss Prevention Test Method The hair loss was applied to the heads of 10 test subjects who were male pattern baldness patients twice daily in the morning and evening for 4 months. The hair that was lost during shampooing was collected, the number of hairs was counted, and the number of hairs lost per day was calculated. In the fourth month after the application of the sample, hair washing was again performed by a professional beautician for 3 days, the hair that was lost during the hair washing was collected, the number of hairs was measured, and the number of hair loss per day was calculated. The hair loss prevention effect was evaluated by the value obtained by the following formula for the number of hair loss per day before the start of the test and after 4 months.
Hair loss prevention effect (%) = (F) / (E)
(E): Number of hair loss per day before application (F): Number of hair loss per day 4 months after application

(4)ヒトフケ防止試験法
男性型脱毛症患者である被試験者10名の頭部に毎日朝夕2回、4カ月間塗布した後のフケの発生状況について評価した。試験結果は、「ふけが少なくなった」と回答した人数で示した。
(4) Anti-dandruff test method The occurrence of dandruff after application to the heads of 10 test subjects who are male pattern baldness patients twice a day for 4 months was evaluated. The test results are shown by the number of respondents who answered that “dandruff was reduced”.

実施例1〜4、比較例1〜2
表1に示す処方の育毛料を常法に従って作成し、前記の諸試験を実施して評価を行った。その結果を併せて表1に示す。
Examples 1-4, Comparative Examples 1-2
A hair restoration having the formulation shown in Table 1 was prepared according to a conventional method, and the above tests were performed for evaluation. The results are also shown in Table 1.

表1から明らかなように、本発明の育毛料は、比較例と比べて明らかに毛乳頭細胞増殖促進効果、毛成長促進効果、毛成長促進度、脱毛防止、フケ防止のいずれの評価においても優れていた。   As is clear from Table 1, the hair-growth material of the present invention clearly has a hair papillary cell proliferation-promoting effect, hair growth-promoting effect, hair growth-promoting effect, hair loss prevention, and anti-dandruff evaluation in comparison with the comparative example. It was excellent.

以下、本発明の育毛料のその他の処方例を実施例として挙げる。なお、これらの実施例の本発明育毛料についても、上記の毛乳頭細胞増殖促進効果、毛成長促進効果、毛成長促進度、脱毛防止、フケ防止効果を検討したところ、いずれの実施例においても、優れた特性を有しており良好であった。   Hereinafter, the other prescription example of the hair restorer of this invention is given as an Example. In addition, for the hair growth material of the present invention of these examples, the above-described hair papilla cell proliferation promoting effect, hair growth promoting effect, hair growth promoting degree, hair loss prevention, anti-dandruff effect were examined. It had excellent characteristics and was good.

実施例5(トニック)
配合量(%)
(1)95%エタノール 60.0
(2)γ−アミノ−β−ヒドロキシ酪酸 0.5
(3)ニコチン酸ベンジル 0.01
(4)α−リポ酸 0.1
(5)プロピレングリコール 2.0
(6)トウヒエキス(一丸ファルコス社製) 0.05
(7)香料 0.1
(8)色素 適 量
(9)精製水 残 部
Example 5 (Tonic)
Compounding amount (%)
(1) 95% ethanol 60.0
(2) γ-amino-β-hydroxybutyric acid 0.5
(3) Benzyl nicotinate 0.01
(4) α-Lipoic acid 0.1
(5) Propylene glycol 2.0
(6) Spruce extract (Ichimaru Falcos) 0.05
(7) Fragrance 0.1
(8) Dye proper amount
(9) Purified water balance

(製法)(1)に、(2)〜(5)、(7)を溶解し、次いで(6)、(8)〜(9)を溶解させたものを添加し、攪拌することにより、透明液状のトニックを得た。 (Manufacturing method) In (1), (2) to (5) and (7) are dissolved, and then (6) and (8) to (9) are added, and the mixture is stirred and transparent. I got a liquid tonic.

実施例6(育毛ローション)
配合量(%)
(1)95%エタノール 45.0
(2)酢酸dl−α−トコフェロール 0.05
(3)6−ベンジルアミノプリン 0.5
(4)ニコチン酸ベンジル 0.01
(5)α−リポ酸 0.1
(6)補酵素Q10 0.003
(7)メントールJP(高砂香料工業社製) 0.3
(8)D−パントテニルアルコール 0.4
(9)イソプロピルメチルフェノール 0.2
(10)水素添加ビサボロール 0.2
(11)ジプロピレングリコール 2.0
(12)ポリオキシエチレン(80)硬化ヒマシ油 0.5
(13)エデト酸四ナトリウム 0.02
(14)L−セリン 0.1
(15)L−スレオニン 0.1
(16)レイシエキス(丸善製薬社製) 0.3
(17)精製水 残 部
Example 6 (hair growth lotion)
Compounding amount (%)
(1) 95% ethanol 45.0
(2) dl-α-tocopherol acetate 0.05
(3) 6-benzylaminopurine 0.5
(4) Benzyl nicotinate 0.01
(5) α-Lipoic acid 0.1
(6) Coenzyme Q10 0.003
(7) Menthol JP (manufactured by Takasago International Corporation) 0.3
(8) D-pantothenyl alcohol 0.4
(9) Isopropylmethylphenol 0.2
(10) Hydrogenated bisabolol 0.2
(11) Dipropylene glycol 2.0
(12) Polyoxyethylene (80) hydrogenated castor oil 0.5
(13) Edetate tetrasodium 0.02
(14) L-serine 0.1
(15) L-threonine 0.1
(16) Ganoderma Extract (Maruzen Pharmaceutical Co., Ltd.) 0.3
(17) Balance of purified water

(製法)(1)に(2)〜(11)を溶解させた。次いで(17)に(12)〜(16)を溶解させたものと混合攪拌し、透明液状の育毛ローションを得た。 (Production Method) (2) to (11) were dissolved in (1). Subsequently, it mixed and stirred with what dissolved (12)-(16) in (17), and obtained the transparent liquid hair growth lotion.

実施例7(エアゾール育毛料)
配合量(%)
<原液処方>
(1)95%エタノール 80.0
(2)トランス−3,4´−ジメチル
−3−ヒドロキシフラバノン 0.5
(3)γ−アミノ−β−ヒドロキシ酪酸 0.5
(4)アデノシン三リン酸 0.05
(5)ラウリル硫酸ナトリウム 0.1
(6)ポリオキシエチエレン(60)硬化ヒマシ油 0.5
(7)サリチル酸 0.1
(8)乳酸ナトリウム 0.05
(9)トウヒエキス(丸善製薬社製) 0.05
(10)レイシエキス(一丸ファルコス社製) 0.05
(11)香料 0.2
(12)色素 微 量
(13)精製水 残 部
<充填処方>
(14)原液 50.0
(15)液化石油ガス 50.0
Example 7 (aerosol hair restorer)
Compounding amount (%)
<Undiluted solution formulation>
(1) 95% ethanol 80.0
(2) Trans-3,4'-dimethyl
-3-Hydroxyflavanone 0.5
(3) γ-amino-β-hydroxybutyric acid 0.5
(4) Adenosine triphosphate 0.05
(5) Sodium lauryl sulfate 0.1
(6) Polyoxyethylene (60) hydrogenated castor oil 0.5
(7) Salicylic acid 0.1
(8) Sodium lactate 0.05
(9) Spruce extract (Maruzen Pharmaceutical Co., Ltd.) 0.05
(10) Ganoderma extract (Ichimaru Falcos) 0.05
(11) Fragrance 0.2
(12) Dye amount
(13) Balance of purified water
<Filling prescription>
(14) Stock solution 50.0
(15) Liquefied petroleum gas 50.0

(製法)原液処方の各成分を混合溶解させて原液を調製し、これを缶に充填し、バルブ装着後、液化石油ガスを充填してエアゾール育毛料を調製した。 (Manufacturing method) Each component of the stock solution formulation was mixed and dissolved to prepare a stock solution, which was filled in a can. After mounting the valve, liquefied petroleum gas was filled to prepare an aerosol hair restorer.

実施例8(乳液型育毛料)
配合量(%)
(1)イソステアリン酸イソプロピル 3.0
(2)カルボキシビニルポリマー(シンタレンK;和光純薬工業社製) 0.3
(3)カルボキシビニルポリマー(シンタレンL;和光純薬工業社製) 0.3
(4)6−ベンジルアミノプリン 0.2
(5)酢酸dl−α−トコフェロール 0.4
(6)補酵素Q10 0.03
(7)ニンジンエキス(丸善製薬社製) 1.0
(8)L−メントール 0.2
(9)イソプロピルメチルフェノール 0.1
(10)水素添加ビサボロール 0.5
(11)スクワラン 0.1
(12)トリエタノールアミン 0.5
(13)ムラサキセンブリ抽出液(丸善製薬社製) 1.0
(14)レイシエキス(一丸ファルコス社製) 0.5
(15)トウヒエキス(丸善製薬社製) 0.5
(16)VC−SS(日本サーファクタント社製) 0.01
(17)L−セリン 0.1
(18)L−スレオニン 0.1
(19)N−アセチル−DL−メチオニン 0.1
(20)魚由来加水分解コラーゲン液 0.5
(21)エタノール 10.0
(22)ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.5
(23)エデト酸二ナトリウム 0.1
(24)香料 0.2
(25)精製水 残 部
Example 8 (Emulsion type hair restorer)
Compounding amount (%)
(1) Isopropyl isostearate 3.0
(2) Carboxyvinyl polymer (Syntalne K; manufactured by Wako Pure Chemical Industries, Ltd.) 0.3
(3) Carboxyvinyl polymer (Syntalne L; manufactured by Wako Pure Chemical Industries, Ltd.) 0.3
(4) 6-benzylaminopurine 0.2
(5) dl-α-tocopherol acetate 0.4
(6) Coenzyme Q10 0.03
(7) Carrot extract (Maruzen Pharmaceutical Co., Ltd.) 1.0
(8) L-menthol 0.2
(9) Isopropylmethylphenol 0.1
(10) Hydrogenated bisabolol 0.5
(11) Squalane 0.1
(12) Triethanolamine 0.5
(13) Murasaki assembly extract (manufactured by Maruzen Pharmaceutical Co., Ltd.) 1.0
(14) Ganoderma extract (Ichimaru Falcos) 0.5
(15) Spruce extract (Maruzen Pharmaceutical Co., Ltd.) 0.5
(16) VC-SS (manufactured by Nippon Surfactant) 0.01
(17) L-serine 0.1
(18) L-threonine 0.1
(19) N-acetyl-DL-methionine 0.1
(20) Fish-derived hydrolyzed collagen solution 0.5
(21) Ethanol 10.0
(22) Polyoxyethylene hydrogenated castor oil (60 EO) 0.5
(23) Disodium edetate 0.1
(24) Fragrance 0.2
(25) Balance of purified water

(製法)(21)に(1),(4)〜(12),(22),(24)を添加し、攪拌溶解した後、(25)に(2)〜(3),(13)〜(20),(23)を添加し、撹拌溶解したものを加えて、乳液型育毛料を得た。 (Production method) (1), (4) to (12), (22), (24) are added to (21), and after stirring and dissolving, (2) to (3), (13) are added to (25). -(20), (23) was added, and what was stirred and dissolved was added to obtain an emulsion type hair restorer.

なお、上記実施例において用いた香料は下記のものである。
In addition, the fragrance | flavor used in the said Example is the following.

以上記載の如く、本発明が脱毛症に対して優れた発毛、養毛、脱毛予防、ふけ防止等の作用を有する育毛料を提供することができることは明らかである。   As described above, it is apparent that the present invention can provide a hair-growth material having effects such as hair growth, hair growth, hair loss prevention, and anti-dandruff which are excellent for alopecia.

Claims (4)

末梢血流促進剤と補酵素を含有することを特徴とする育毛料。 A hair restorer comprising a peripheral blood flow promoter and a coenzyme. 末梢血流促進剤が、γ−アミノ酪酸誘導体、ニコチン酸類、ビタミンE類、トランス−3,4´−ジメチル−3−ヒドロキシフラバノン及び6−ベンジルアミノプリンからなる群より選ばれる少なくとも一種以上である請求項1記載の育毛料。 The peripheral blood flow promoting agent is at least one selected from the group consisting of γ-aminobutyric acid derivatives, nicotinic acids, vitamin Es, trans-3,4'-dimethyl-3-hydroxyflavanone and 6-benzylaminopurine. The hair restorer according to claim 1. 補酵素がコエンザイムQ10またはα−リポ酸から選ばれる1種類以上を配合することを特徴とする請求項1又は2記載の育毛料。 3. The hair restorer according to claim 1 or 2, wherein the coenzyme is blended with at least one selected from coenzyme Q10 and α-lipoic acid. さらに、レイシ、トウヒから抽出されたエキス1種類以上を配合することを特徴とする請求項1〜3いずれか記載の育毛料。 Furthermore, 1 or more types of extract extracted from litchi and spruce is mix | blended, The hair restorer in any one of Claims 1-3 characterized by the above-mentioned.
JP2006025226A 2006-02-02 2006-02-02 Hair growth promoter Pending JP2007204426A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006025226A JP2007204426A (en) 2006-02-02 2006-02-02 Hair growth promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006025226A JP2007204426A (en) 2006-02-02 2006-02-02 Hair growth promoter

Publications (1)

Publication Number Publication Date
JP2007204426A true JP2007204426A (en) 2007-08-16

Family

ID=38484200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006025226A Pending JP2007204426A (en) 2006-02-02 2006-02-02 Hair growth promoter

Country Status (1)

Country Link
JP (1) JP2007204426A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009079018A (en) * 2007-09-27 2009-04-16 Kao Corp Scalp cosmetic
JP2010150203A (en) * 2008-12-25 2010-07-08 Lion Corp Hair growing agent composition
JP2013159592A (en) * 2012-02-08 2013-08-19 Sansho Seiyaku Co Ltd External agent for preventing gray hair
JP2015013849A (en) * 2013-06-06 2015-01-22 株式会社東洋新薬 Hair-growing composition, hair dermal papilla cell growth promotion composition, fgf-7 production promotion composition, vegf production promotion composition, blood flow promotion composition for skin surface, and cosmetic
JP2015222248A (en) * 2014-04-28 2015-12-10 株式会社ミルボン Method for evaluating carbonylation level, method for screening component reducing carbonylation level and carbonylation level reduction agent
JP2017031118A (en) * 2015-08-04 2017-02-09 三省製薬株式会社 Anti-white hair agent
JP2017210420A (en) * 2016-05-24 2017-11-30 三省製薬株式会社 Hair growing agent composition
JP2020070242A (en) * 2018-10-29 2020-05-07 アドファーマ株式会社 Hair growth and hair restoration improver

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009079018A (en) * 2007-09-27 2009-04-16 Kao Corp Scalp cosmetic
JP2010150203A (en) * 2008-12-25 2010-07-08 Lion Corp Hair growing agent composition
JP2013159592A (en) * 2012-02-08 2013-08-19 Sansho Seiyaku Co Ltd External agent for preventing gray hair
JP2015013849A (en) * 2013-06-06 2015-01-22 株式会社東洋新薬 Hair-growing composition, hair dermal papilla cell growth promotion composition, fgf-7 production promotion composition, vegf production promotion composition, blood flow promotion composition for skin surface, and cosmetic
JP2015222248A (en) * 2014-04-28 2015-12-10 株式会社ミルボン Method for evaluating carbonylation level, method for screening component reducing carbonylation level and carbonylation level reduction agent
JP2017031118A (en) * 2015-08-04 2017-02-09 三省製薬株式会社 Anti-white hair agent
JP2017210420A (en) * 2016-05-24 2017-11-30 三省製薬株式会社 Hair growing agent composition
JP2020070242A (en) * 2018-10-29 2020-05-07 アドファーマ株式会社 Hair growth and hair restoration improver

Similar Documents

Publication Publication Date Title
JP4603192B2 (en) Hair scalp composition
JP2007204426A (en) Hair growth promoter
JP4554805B2 (en) Hair nourishing
KR20130069512A (en) Skin external composition comprising tangeretin
RU2396940C2 (en) Hair tonic
EP3395324B1 (en) Anti-aging agent and anti-aging composition for skin
JP2009079018A (en) Scalp cosmetic
JP2006028026A (en) Hair-growing agent
JP4469617B2 (en) Hair restoration
KR20120051199A (en) Cosmetic compositions for hair or scalp to prevent hair loss and promote growing hair
JP4032246B2 (en) White hair prevention and improvement agent
JPH11269043A (en) Cosmetic for scalp and hair
JP2005200357A (en) Hair-fostering cosmetic
JPH03167113A (en) Hair regenerating agent
JP2001288046A (en) Composition for scalp and hair
JPH09241137A (en) Hair crowing and restoring agent
JP3853773B2 (en) Hair nourishing
JP3542700B2 (en) Head composition
JPH11302131A (en) Cosmetic for scalp and hair
JP2012006902A (en) External preparation set for skin improvement, and beauty method using the same
KR102386651B1 (en) Composition for preventing or treating hair loss comprising tiplaxtinin
JPH11302128A (en) Cosmetic for scalp and hair
JP3808417B2 (en) Hair nourishing
JP2005089392A (en) Hair tonic
JP4041451B2 (en) Hair nourishing

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20071010

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071012